跳到主要內容區塊
:::
醫師介紹
Print
    蔡偉 TSAY Feng-Woei
    蔡偉 TSAY Feng-Woei
    看診科別
    主治項目
    • 1.腸胃道疾病內視鏡治療術、消化道息肉及早期癌切除
    • 2.幽門螺旋桿菌除菌治療研究
    • 3.肝癌膽道癌治療,肝硬化暨併發症治療
    • 4. B肝、C肝病毒性肝炎治療
    專長
    • 1.腸胃道疾病內視鏡治療術、消化道息肉及早期癌切除
    • 2.幽門螺旋桿菌除菌治療研究
    • 3.肝癌膽道癌治療,肝硬化暨併發症治療
    • 4. B肝、C肝病毒性肝炎治療
    現職
    • 高雄榮總胃腸科主治醫師
    • Email: fwchaie@vghks.gov.tw
    學歷
    • 中國醫藥大學醫學士
    經歷
    • 高雄榮總胃腸科主治醫師 2007.01-迄今
    • 國立陽明醫學大學醫學系兼任助理教授 2018.9 -迄今
    • 美國約翰霍普金斯大學醫學院訪問學者2015.10-2016.12
    • 育部部定助理教授2015.1
    • 高雄榮總 內科部住院醫師 2001-2006
    證照
    • 消化系內科專科醫師證書、超音波專業醫師證書、消化系內試鏡專科醫師證書、台灣醫學教育學會一般醫學師資證書
    專案計畫
    • 幽門螺旋桿菌除菌治療研究
    • 內視鏡治療術、消化道息肉及早期癌切除
    論著
    • 1. Tsay FW,, Hsu PI. H. pylori infection and extra-gastroduodenal diseases.J Biomed Sci.2018 Aug 29;25(1):65. doi: 10.1186/s12929-018-0469-6.
    • 2. Tsai TJ, Chan HH, Lai KH,Shih CA, Kao SS, Sun WC, Wang EM1,Tsai WL, Lin KH, Yu HC, Chen WC, Wang HM, Tsay FW, Lin HS, Cheng JS, Hsu PI. Gallbladder function predicts subsequent biliary complications in patients with common bile duct stones after endoscopic treatment? BMC Gastroenterol.2018 Feb 27;18(1):32. doi: 10.1186/s12876-018-0762-6.
    • 3. Hsu PI, Tsai FW, Kao SS, Hsu WH, Cheng JS, Peng NJ, Tsai KW, Hu HM, Wang YK, Chuah SK, Chen A, Wu DC. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial. Am J Gastroenterol.2017 Sep;112(9):1374-1381. doi: 10.1038/ajg.2017.195. Epub 2017 Jul 18.
    • 4. Hsu PI,Wu DC, Tsay FW,Cheng JS,Liu CP,Lai KH,Chen WC,Wang HM,Tsai TJ,Tsai KW,Kao SS. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial. Am J Gastroenterol.2017 Feb;112(2):282-289. doi: 10.1038/ajg.2016.526. Epub 2016 Dec 6.
    • 5.Tsay FW, Wu DC, Yu HC, Kao SS, Lin KH, Cheng JS, Wang HM, Chen WC, Sun WC, Tsai KW, Hsu PI. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. Antimicrob Agents Chemother.2017 Oct 24;61(11). pii: e00140-17. doi: 10.1128/AAC.00140-17.
    • 6. Ping-I Hsu,Kwok-Hung Lai,Feng-Woei Tsay,Jin-Shiung Cheng,E-Ming Wang,Rong-Jer Lai, Successful hemostasis and resection of a bleeding gastric polyp by endoscopic banding ligation in a uremic patient taking antiplatelet agent. Springerplus. 2016; 5(1): 1806. doi:10.1186/s40064-016-3499-0
    • 7. Wu DC, Kuo CH, Tsay FW, Hsu WH, Chen A, Hsu PI. A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection. Medicine (Baltimore) 2016;95(11):e2698. doi: 10.1097/MD.0000000000002698.
    • 8. Hsu PI, Kao SS, Wu DC, Chen WC, Peng NJ, Yu HC, Wang HM, Lai KH, Cheng JS, Chen A, Chuah SK, Tsay FW*; Taiwan Acid-Related Disease Study Group.A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection. Medicine (Baltimore) 2015;94(48):e2104. doi: 10.1097/MD.0000000000002104. (SCI)
    • 9. Chen WC, Cheng JS, Chiang PH, Tsay FW, Chan HH, Chang HW, Yu HC, Tsai WL, Lai KH, Hsu PI. A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy. PLoS One. 2015;10(6):e0131545. doi: 10.1371/journal.pone.0131545.
    • 10. Tsay FW, Wu DC, Kao SS, Tsai TJ, Lai KH, Cheng JS, Chan HH, Wang HM, Tsai WL, Tseng HH, Peng NJ, Hsu PI. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial. Helicobacter. 2015 ;20(1):71-7. doi: 10.1111/hel.12176. (SCI)
    • 11. Sun WC, Hsu PI, Yu HC, Lin KH, Tsay FW, Wang HM, Tsai TJ, Chen WC, Lai KH, Cheng JS. The Compliance of Doctors with Viral Hepatitis B Screening andAntiviral Prophylaxis in Cancer Patients Receiving CytotoxicChemotherapy Using a Hospital-based Screening Reminder System. PLOS ONE 2015;10(2):e0116978. doi: 10.1371/journal.pone. 0116978. (SCI)
    • 12. Hsu PI, Wu DC, Chen WC, Tseng HH, Yu HC, Wang HM, Kao SS, Lai KH, Chen A, Tsay FW*. Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection. Antimicrob Agents Chemother. 2014 Oct;58(10):5936-42. doi: 10.1128/AAC.02922-14. (SCI)
    :::